Clinical Trials
3 trialsNCT07622706 2026-06-03
Firmonertinib in Perioperative Treatment of Resectable Stage II-IIIB EGFR-mutated Lung Adenocarcinoma
Peking University Cancer Hospital & Institute
Phase 2 Not yet recruiting
NCT07612722 2026-05-29
Sub-lobectomy vs Lobectomy in IIA-IIIB NSCLC After Neoadjuvant IO+Chemo
Guangdong Provincial People's Hospital
Phase NA Recruiting
NCT05378763 2026-05-22
PINNACLE
Spectrum Pharmaceuticals, Inc
Phase 3 Suspended